Loading data
MMEDNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | 3.1 bn USD | 2.72 bn USD | 2.47 bn USD |
| Cost of revenue | 1.42 bn USD | 1.19 bn USD | 1.03 bn USD |
| Gross profit | 1.68 bn USD | 1.53 bn USD | 1.44 bn USD |
| Selling, general and administrative expense | 1.18 bn USD | 1.08 bn USD | 1.06 bn USD |
| Operating profit | -190 m USD | -146 m USD | -69 m USD |
| Profit before tax | -189 m USD | -147 m USD | -70 m USD |
| Income tax expense | 128 m USD | 52 m USD | 38 m USD |
| Net income (reported basis) | -333 m USD | -213 m USD | -112 m USD |
| Basic earnings per share | -1.3 USD/share | -0.84 USD/share | -0.44 USD/share |
| Diluted earnings per share | -1.3 USD/share | -0.84 USD/share | -0.44 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.